 |
|
Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
Anne M. Lachiewicz, MPH;
Marianne Berwick, PhD, MPH;
Charles L. Wiggins, PhD, MSPH;
Nancy E. Thomas, MD, PhD
Arch Dermatol. 2008;144(4):515-521.
Objective To compare the prognosis of patients with scalp or neck (scalp/neck) melanomas with that of patients with melanomas at other sites in a large, population-based national data set controlling for known prognostic factors.
Design Retrospective cohort study using US cancer registries that constitute the Surveillance, Epidemiology, and End Results 13 Registries (SEER-13) database.
Patients A total of 51 704 non-Hispanic white adults in the United States with a first invasive cutaneous melanoma reported during the period 1992 to 2003.
Main Outcome Measures Kaplan-Meier survival estimates were used to compare melanoma-specific survival by anatomic site at 5 and 10 years. Multivariate Cox models were used to examine the hazard ratio (HR) of melanoma-specific death associated with scalp/neck melanoma compared with melanoma of the extremities after controlling for other variables.
Results The 5- and 10-year Kaplan-Meier survival probabilities for scalp/neck melanoma were 83.1% and 76.2%, respectively, compared with 92.1% and 88.7%, respectively, for melanoma of the other sites, including extremities, trunk, face, and ears (log-rank test; P < .001). In a multivariate Cox model, the patients with melanoma of the scalp/neck died of melanoma at 1.84 times (HR, 1.84; 95% confidence interval, 1.62-2.10) the rate of those with melanoma on the extremities, controlling for age, Breslow thickness, sex, and ulceration. Neither excluding cases of lentigo maligna and nodular melanoma nor controlling for lymph node involvement materially changed the HR for scalp/neck melanoma.
Conclusions A notable survival difference remained between scalp/neck melanoma and melanoma of other sites even after adjustment for important prognostic factors. This finding has implications for screening and public health recommendations, and we urge physicians, physician assistants, nurses, and nurse practitioners to examine the scalp/neck carefully during routine skin examinations. Further studies are needed to understand the biological or environmental factors leading to survival differences by anatomic site.
Author Affiliations: Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill (Ms Lachiewicz and Dr Thomas); and Department of Internal Medicine, University of New Mexico, Albuquerque (Drs Berwick and Wiggins).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Health Promotion Programs for Melanoma Prevention: Screw or Spring?
David Hill and Robin Marks
Arch Dermatol. 2008;144(4):538-540.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Tumor Location Is an Independent Prognostic Factor in Head and Neck Merkel Cell Carcinoma
Smith et al.
Otolaryngol Head Neck Surg 2011;0:0194599811431789v1-194599811431789.
ABSTRACT
| FULL TEXT
Skin Cancer Knowledge, Attitudes, and Behaviors in the Salon: A Survey of Working Hair Professionals in Houston, Texas
Bailey et al.
Arch Dermatol 2011;147:1159-1165.
ABSTRACT
| FULL TEXT
Morphologic Features and Natural History of Scalp Nevi in Children
Gupta et al.
Arch Dermatol 2010;146:506-511.
ABSTRACT
| FULL TEXT
Melanoma Prognosis Based on Anatomic Site
Journal Watch Dermatology 2008;2008:1-1.
FULL TEXT
Health Promotion Programs for Melanoma Prevention: Screw or Spring?
Hill and Marks
Arch Dermatol 2008;144:538-540.
FULL TEXT
|
